Notification That Quarterly Report Will Be Submitted Late (nt 10-q)
June 14 2013 - 4:05PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 12B-25
SEC File Number: 000-28761
CUSIP Number: 14160X 203
NOTIFICATION OF LATE FILING
(Check One):
¨
Form
10-K
¨
Form 11-K
¨
Form
20-F
x
Form 10-Q
¨
Form
N-SAR
For Period Ended:
Quarter ended April 30, 2013
¨
|
Transition Report on Form 10-K
|
¨
|
Transition Report on Form 10-Q
|
¨
|
Transition Report on Form 20-F
|
¨
|
Transition Report on Form N-SAR
|
¨
|
Transition Report on Form 11-K
|
|
|
For the Transition Period Ended:
__________________________
Read attached instruction
sheet before preparing form. Please print or type.
Nothing in this form
shall be construed to imply that the Commission has verified any information contained herein.
If the notification relates to a
portion of the filing checked above, identify the item(s) to which the notification relates:
_______________________________________________
PART I
REGISTRANT INFORMATION
Full name of Registrant
CardioGenics
Holdings Inc.
Former name if applicable
_____________________________________________
Address of principal executive office
(Street and Number)
6295 Northam Drive, Unit 8
City, state and zip code
Mississauga,
Ontario L4V 1W8
PART II
RULE 12b-25 (b)
AND
(c)
If the subject report
could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following
should be completed. (Check box if appropriate.)
x
|
(a)
|
The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
|
|
|
|
x
|
(b)
|
The subject annual report, semi-annual report, transition report on Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or before the 15th calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or portion thereof will be filed on or before the 5th calendar day following the prescribed due date; and
|
|
|
|
¨
|
(c)
|
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART III
NARRATIVE
State below in reasonable
detail the reasons why Forms 10-K, 11-K, 20-F, 10-Q, N-SAR or the transition report portion thereof could not be filed within the
prescribed time period. (Attach extra sheets if needed).
Records and documentation necessary for
completion of the narrative and financial statements for the report were not available in time to complete the Form 10-Q of the
Registrant for the quarterly period ending April 30, 2013. The Registrant will file such report on or before June 19, 2013.
PART IV
OTHER INFORMATION
(1)
|
Name and telephone number of person to contact in regard to this notification
|
|
|
|
|
|
Yahia Gawad
|
(905)
|
673-8501
|
|
(Name)
|
(Area Code)
|
(Telephone Number)
|
|
|
|
|
|
|
|
|
(2)
|
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).
|
|
|
|
|
|
x
Yes
¨
No
|
|
|
|
|
(3)
|
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
|
|
|
|
|
|
¨
Yes
x
No
|
If so: attach an
explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
CardioGenics Holdings Inc.
(Name
of Registrant as Specified in Charter)
has caused this notification to be signed
on its behalf by the undersigned thereunto duly authorized.
Date
June 14, 2013
|
By:
/s/
Yahia Gawad
|
|
Name:
|
Yahia Gawad
|
|
Title:
|
Chief Executive Officer
|
CardioGenics (CE) (USOTC:CGNH)
Historical Stock Chart
From Sep 2024 to Oct 2024
CardioGenics (CE) (USOTC:CGNH)
Historical Stock Chart
From Oct 2023 to Oct 2024